Aberrant Let7a/HMGA2 Signaling Activity Associated With Unique Clinical Phenotypes in JAK2-Mutated Myeloproliferative Neoplasms

The findings from a recent study suggest that, in a subset of MPN patients, the Let7a/HMGA2 axis plays a prominent role in the pathogenesis of the disease and leads to unique clinical phenotypes.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.